Amit Gupta Sells 23,416 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of Cardlytics stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now owns 122,676 shares in the company, valued at approximately $1,461,071.16. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Cardlytics Stock Performance

Shares of CDLX stock opened at $11.59 on Friday. The company’s fifty day simple moving average is $11.20 and its 200-day simple moving average is $9.65. Cardlytics, Inc. has a 52 week low of $4.94 and a 52 week high of $20.52. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 1.91. The company has a market cap of $558.05 million, a PE ratio of -3.35 and a beta of 1.44.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings results on Thursday, March 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%. The firm had revenue of $89.17 million for the quarter.

Institutional Investors Weigh In On Cardlytics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Cardlytics by 13.0% during the 3rd quarter. Vanguard Group Inc. now owns 2,011,705 shares of the company’s stock worth $33,193,000 after buying an additional 231,303 shares during the period. Invesco Ltd. increased its stake in Cardlytics by 538.1% during the 3rd quarter. Invesco Ltd. now owns 803,241 shares of the company’s stock worth $13,253,000 after buying an additional 677,354 shares during the period. General Equity Holdings LP increased its stake in Cardlytics by 31.0% during the 4th quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after buying an additional 147,843 shares during the period. LPL Financial LLC increased its position in shares of Cardlytics by 27.5% in the 3rd quarter. LPL Financial LLC now owns 424,150 shares of the company’s stock worth $6,998,000 after purchasing an additional 91,400 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. bought a new stake in shares of Cardlytics in the 3rd quarter worth approximately $5,258,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analysts Forecast Growth

CDLX has been the topic of a number of research analyst reports. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and lifted their price target for the company from $10.00 to $18.00 in a report on Friday, March 15th. Lake Street Capital raised their target price on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Needham & Company LLC raised their target price on shares of Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, April 9th.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.